Evidence map›Paper›PMID 21436291›Full record

ArticleJournal of the American Society of Nephrology : JASN2011

β-catenin causes renal dysplasia via upregulation of Tgfβ2 and Dkk1.

Darren Bridgewater, Valeria Di Giovanni, Jason E Cain, Brian Cox, Madis Jakobson, Kirsi Sainio, Norman D Rosenblum

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Blocking TGF-Journal of the American Society of Nephrology : JASN · 2017
    Article
  12. Developmental Origins for Kidney Disease Due to Shroom3 Deficiency.Journal of the American Society of Nephrology : JASN · 2016
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. The Good and Bad of β-Catenin in Kidney Development and Renal Dysplasia.Frontiers in cell and developmental biology · 2015
    Review
  18. Article
  19. Patterning the renal vascular bed.Seminars in cell & developmental biology · 2014
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Darren BridgewaterProgram in Developmental and Stem Cell Biology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8.
Valeria Di Giovanni
Jason E Cain
Brian Cox
Madis Jakobson
Kirsi Sainio
Norman D Rosenblum
Biologie du Développement et Cellules SouchesDivision of Undergraduate Education · USUniversity of Helsinki · FI

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Renal dysplasia, defined by defective ureteric branching morphogenesis and nephrogenesis, is the major cause of renal failure in infants and children. Here, we define a pathogenic role for a β-catenin-activated genetic pathway in murine renal dysplasia. Stabilization of β-catenin in the ureteric cell lineage before the onset of kidney development increased β-catenin levels and caused renal aplasia or severe hypodysplasia. Analysis of gene expression in the dysplastic tissue identified downregulation of genes required for ureteric branching and upregulation of Tgfβ2 and Dkk1. Treatment of wild-type kidney explants with TGFβ2 or DKK1 generated morphogenetic phenotypes strikingly similar to those observed in mutant kidney tissue. Stabilization of β-catenin after the onset of kidney development also caused dysplasia and upregulation of Tgfβ2 and Dkk1 in the epithelium. Together, these results demonstrate that elevation of β-catenin levels during kidney development causes dysplasia.

Indexed as

AnimalsApoptosisbeta CateninCell ProliferationDisease Models, AnimalFemaleIntercellular Signaling Peptides and ProteinsKidneyMiceMice, Mutant StrainsMorphogenesisPregnancySignal TransductionTransforming Growth Factor beta2Up-RegulationUreterbeta CateninDKK1 protein, humanIntercellular Signaling Peptides and ProteinsTransforming Growth Factor beta2Wnt Proteins

Identifiers

PMID21436291
PMCPMC3065227
OpenAlexW2122304605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.